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IgG4-related sclerosing cholangitis is histologically characterized by the infiltration of 
IgG4-positive plasma cells and sclerosing change. Moreover, several cases of carcinoma 
cases accompanied by IgG4-positive cells in tissue and increased serum IgG4 levels 
have been reported, but the association between cancer-associated immunity and an 
IgG4 reaction is still unclear. In this study, we examined the infiltration of IgG4-positive 
cells in extrahepatic cholangiocarcinoma and the pathological significance of the IgG4 
reaction found in cancer tissues in terms of the evasion of immune surveillance by Treg 
cells. Immunohistochemistry for IgG4, Foxp3, CD4, and CD8 was performed using 68 
surgical specimens from patients with extrahepatic cholangiocarcinoma and positive 
cells were investigated, particularly within and around cancerous tissues. Consequently, 
although IgG4+ cells were few (average, <10 cells/ high power field) in the majority of 
cases, ≥10 and ≥50 cells were found in 37% and 6% of cases, respectively. IgG4+ cells 
were predominantly found in the invasive front of carcinoma tissue. In these cases 
accompanying ≥10 IgG4+ cells, Foxp3+ Treg cells were also distinguishable and a 
positive correlation was found between the Foxp3+/CD4+ ratio and IgG4+ cell count, 
but few CD8+ cells invaded cancer cells (<10 cells). In conclusion, extrahepatic 
cholangiocarcinomas are often accompanid by the significant infiltration of IgG4+ cells 
and the IgG4 reaction showed a positive and negative correlation with Foxp3+ and 
CD8+ cells, respectively, suggesting the evasion of immune surveillance associated 
with CD8+ cytotoxic T cells via the regulatory function of Foxp3+ Treg cells. 
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INTRODUCTION 
IgG4 is a minor immunoglobulin subtype composing 3-6% of all the IgG 
circulating in adults [1], but important for the formation of IgG4-related diseases that 
feature elevated serum IgG4 levels and abundant infiltration with IgG4-positive plasma 
cells in affected organs [1-3]. IgG4-related diseases incorporate various IgG4-associated 
inflammatory disorders including autoimmune pancreatitis (AIP), sclerosing 
cholangititis, sialoadenitis, retroperitoneal fibrosis, inflammatory abdominal aortic 
aneurism, intestinal pneumonia, interstitial nephritis, lymphadenopathy, and 
inflammatory pseudotumor [3-11]. Recently, cases of IgG4-related diseases were 
accumulated according to the widespread recognition of this disease entity and 
clinicopathological characterization for a differential diagnosis has been clarified. 
However, the pathological significance of increased serum IgG4 levels and marked 
infiltration of IgG4-positive plasma cells in target organs is still unknown.  
IgG4-related diseases have varied clinical symptoms that may include features 
similar to malignant tumors. Because most IgG4-related diseases involving AIP are 
resolved by corticosteroid treatment, the diagnosis, particularly differentiation from 
malignant tumors, is very important [12-14]. Although using an upper normal limit for 
serum IgG4 of 135 mg/dL, Hamano et al [1], reported a diagnostic 95% sensitivity and 
97% specificity (vs pancreatic cancer) for AIP, pathological examination is necessary to 
differentiate IgG4-related diseases from tumors in any organs. Moreover, several 
investigators have recently reported on patients with pancreatic cancer accompanying 
elevated serum IgG4 levels and some cases are speculated to arise from AIP [15-17]. 
Raina et al. [18] reported that as many as 7% of patients with pancreatic cancer have 
serum IgG4 levels above 135mg/dL and concluded that in patients with pancreatic mass 
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lesions and suspicion of cancer, an IgG4 level measuring between 135 and 200mg/dL 
should be interpreted cautiously and not accepted as diagnostic of AIP without further 
evaluation. Some kind of association between tumor immunity and IgG4 reaction has 
been assumed, but detailed information is not available. 
As the pathogenesis of the IgG4 reaction in IgG4-related diseases, the 
participation of CD4+CD25+FOXP3+ regulatory T cells (Treg) and Th2-type helper T 
cells has been speculated [19]. Treg cells play a role in the progression of various 
malignant tumors, particularly in controlling the immune response against pancreatic 
ductal carcinoma from the premalignant stage to established cancer [20]. A high 
prevalence of Treg cells, moreover, seems to indicate a poor prognosis [20]. 
In this study, we retrospectively evaluated IgG4-positive plasma cells in 
extrahepatic cholangiocarcinomas including common bile duct cancers, gallbladder 
cancers, and cancers of the papilla of Vater and investigated the significance of the IgG4 
reaction in cholangiocarcinoma from the point of view of tumor immune escape 
mediated by Treg cells. 
 
MATERIALS and METHODS 
Patients and tissue preparations: Formalin-fixed and paraffin-embedded 
sections of 68 surgically resected specimens from 39 patients with gallbladder cancers, 
21 patients with common bile duct cancers, and 8 patients with cancer of the papilla of 
Vater (Average age 74 y.o, male/female=38/30) were obtained from the registry of liver 
diseases in the Department of Pathology, Kanazawa University School of Medicine. In 
30 cases, follow-up data was also obtained in the present study. Each 
cholangiocarcinoma was classified histologically as well- (including papillary), 
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moderately, or poorly differentiated, based on the predominant histologic grade. Special 
histological types such as adenosquamous carcinoma and mucinous carcinoma were not 
included in the present study. Four micrometer-thick serial sections were prepared from 
each formalin-fixed, paraffin-embedded block. Each one was stained with Hematoxylin 
and eosin (H&E), and the others were used for immunohistochemistry.  
Immunohistochemistry: The deparaffinized and rehydrated sections were 
microwaved in EDTA buffer for IgG4 and Foxp3, in buffer at pH 9 for CD4 and in 
citrate buffer for CD8 for 20 min in a microwave oven. Following the blocking of 
endogenous peroxidase, these sections were incubated at 4°C overnight with antibodies 
against IgG4 (mouse monoclonal; diluted 1:200; Southern Biotech, Birmingham, AL, 
USA), Foxp3 (mouse monoclonal; 10 μg/ml; Abcam, Cambridge, UK) , CD4 (mouse 
monoclonal; neat, Nichirei, Tokyo, Japan) or CD8 (mouse monoclonal; diluted 1:20, 
Dako, Tokyo, Japan), and then at room temperature for 1hr with anti-mouse 
immunoglobulins conjugated to a peroxidase-labeled dextran polymer (Simple Staining 
Kit; Nichirei). After a benzidine reaction, sections were counterstained lightly with 
hematoxylin. No positive staining was obtained when the primary monoclonal antibody 
was replaced with an isotype-matched, non-immunized immunoglobulin as a negative 
control of the staining procedures. 
Histological examination: In addition to histological observation by H&E 
staining, the distribution of the immuno-positive cells was examined. In a primary 
survey, we examined all tumorous area in each specimen and, for counting IgG4+, 
Foxp3+, CD4+, or CD8+ mononuclear cells, selected three representative areas 
containing IgG4+ plasma cells, and expressed results as the mean number of each 
immuno-positive cell in high-power fields (HPFs). For semi-quantitative evaluation of 
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the IgG4 staining, the cases with ≥10 and ˂10 IgG4+ cells/HPF on average were 
evaluated as IgG4-positive and -negative cases, respectively. The ratio of Foxp3+ to 
CD4+ cells was calculated for the three selected area in each case and the average ratio 
(Foxp3/CD4) was compared between IgG4-rich and -poor cases, because the absolute 
number of Foxp3+ cells was prominently affected by the degree of infiltrating 
mononuclear cells. Moreover, the average number of CD8+ cytotoxic T cells (CTLs) 
within carcinoma cells was evaluated to estimate the degree of host immune response 
against cancer. 
Statistical Analysis: Data were analyzed using tSpeason’s correlation 
coefficient test. Survival curves to evaluate the association between prognosis and IgG4 
reactions were calculated by the Kaplan-Meier method, and analyses were conducted 




Detection and distribution of IgG4+ cells in extrahepatic 
cholangiocarcinoma: Immunohistochemistry revealed IgG4+ plasma cells to be 
scattered within and around cancerous nests in most cases (Fig.1). Particularly, around 
nests and in the invasive area facing a non-cancerous biliary wall and surrounding 
fibroadipose tissue, these positive cells were prominent with some intermingling of 
other inflammatory cells (Fig.2). Moreover, one characteristic feature of IgG4-related 
diseases, the perineural infiltration of IgG4+ cells, was commonly seen in extrahepatic 
cholangiocarcinomas. In contrast, desmoplastic change and vascular invasion by cancer 
cells are usually seen in extrahepatic cholangiocarcinomas, but other features of 
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IgG4-related diseases, obliterative phlebitis caused by IgG4+ cells and storiform-type 
fibrosis, are rare. 
A quantitative evaluation of IgG4+ cells revealed that 25 (37%), 19 (28%), and 
4 (6%) of 68 cholangiocarcinoma patients had ≥10, ≥20, and ≥50 IgG4+ cells/HPF, 
respectively. There was no correlation between the density of IgG4+ cells and any 
clinicopathological factor including age, gender, anatomical location (common bile 
ducts, gallbladder, and the papilla of Vater), or the histological differentiation (well-, 
moderately, and poorly) of extrahepatic cholangiocarcinomas. 
Association between IgG4 reaction and Foxp3+ Treg cells: The association 
between IgG4+ and Foxp3+ cells was evaluated in each case. Foxp3+ Treg cells were 
scattered in most cases with a marked IgG4 reaction (Fig.3). The relation between the 
IgG4 reaction and Foxp3+ Treg cells is shown in Fig.4. In IgG4-rich cases (≥10 IgG4+ 
cells/HPF), the ratio of Foxp3+/CD4+ cells correlated closely with the IgG4+ cell count, 
though it is varied in IgG4-poor cases (˂10 IgG4+ cells/HPF). 
Association between IgG4 reaction and CD8+ CTLs: CD8+ CTLs were 
scattered at various intensities in each case irrespective of within and around cancer 
nests. As a marker of immune activity against cancers, CTLs invaded cancerous nests 
resembling IELs, which are found in non-neoplastic biliary epithelial layers of biliary 
diseases such as primary biliary cirrhosis (Fig.5)[21] Consequently, patients with 
marked CD8+ CTLs showed scant IgG4 reaction (IgG4-poor cases) and all IgG4-rich 
cases had few CD8+ CTLs (˂10 cells/HPF) (Fig.6)  
Association between IgG4 reaction and patient’s survival: After the surgical 
resection of extrahepatic cholangiocarcinomas, of the 30 patients with available 
outcome data, 21 died from recurrence of cancers. By the Kaplan-Meier estimator, the 
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overall survival curve for the 30 patients is shown in Fig.7 The patients with 2˂0 IgG4+ 
cells/HPF had a better prognosis than those with ≥20 cells (p<0.05). 
 
DISCUSSION 
Elevated serum IgG4 levels and the infiltration of organs by numerous IgG4+ 
plasma cells are clinicopathological hallmarks of IgG4-related diseases. Moreover, 
obliterative phlebitis, storiform-type sclerosing fibrosis, and sometimes mass 
forming-type, are also characteristics of this disease category. It is clinically and 
pathologically important to differentiate IgG4-related diseases and tumors of affected 
organs. In particular, because desmoplastic change is a common feature of biliary and 
pancreatic cancers, IgG4-related diseases and cancers in these organs show similar 
radiological behaviors. Moreover, patients with pancreatic adenocarcinoma 
accompanying an IgG4 reaction and/or elevated serum IgG4 levels [16, 18, 22, 23] and 
with pancreatic and biliary cancers arising from IgG4-related disease [16, 24, 25] have 
been reported, though a cause-and-effect relationship between the IgG4 reaction and 
cancers has not been demonstrated. Therefore, the presence of IgG4+ cells is not a 
histological hallmark of IgG4-related diseases and the IgG4 reaction is speculated to 
occur non-specifically in carcinoma tissues. In this study, we retrospectively examined 
IgG4 reactions in cases of extrahepatic cholangiocarcinoma including common bile duct 
cancers, gallbladder cancer, and cancers of the papilla of Vater. Consequently, 10 or 
more IgG4+ cells/HPF were observed in 37% of cases and the cases with marked 
infiltration (≥50 IgG4-positive cells/HPF) and resembling IgG4-related diseases made 
up 6% of the total. For the pathological diagnostic criteria of IgG4-related disease, the 
essential number of IgG4+ cells varied from 5 to 50/HPF depending on the affected 
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organs, but in IgG4-related sclerosing cholangitis, ≥10 IgG4+ cells/HPF is proposed 
according to the HISORt criteria published for AIP [26, 27]. In our cases, therefore, 
several cancers accompanying remarkable IgG4-positive cells (≥50 cells/HPF) 
originated from the preceding IgG4-related disease, but follow-up data prior to 
discovery of cancers is needed to demonstrate this. Irrespective of the patients with 
cholangiocarcinoma and a marked IgG4 reaction and those arising from IgG4-related 
sclerosing cholangitis, the presence of adenocarcinoma should be taken into account in 
the pathological diagnosis of IgG4-related cholangitis, particularly using small 
specimens such as biopsy materials.  
The present study demonstrated that a IgG4 reaction is often found to some 
degree in extrahepatic cholangiocarcinoma as well as IgG4-related diseases. Moreover, 
the perineural infiltration of IgG4+ cells which is a feature of IgG4-related cholangitis 
and AIP, was prominent in IgG4-rich cholangiocarcinoma cases. In contrast, patients 
with IgG4-related cholangitis are generally older men (85%) [26], but this male 
domination was not found in the IgG4 reaction of cholangiocarcinoma. Obliterative 
phlebitis and storiform fibrosis are also characteristic of IgG4-related diseases, but rare 
in cholangiocarcinoma. These histological features of IgG4-related diseases differing 
from cholangiocarcinoma are not located at the superficial biliary mucosa, unfortunately 
suggesting that these characteristic findings are not useful for a differential diagnosis 
using biopsy specimens. The IgG4 reaction is not a specific immunereaction of 
IgG4-related diseases, but the immunopathogenesis of IgG4 reactions should be 
different in IgG4-related diseases and cancers. Further study is necessary to clarify the 
histogenesis of IgG4 reactions. 
IgG4 does not have the ability to activate complement and its physiological and 
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pathological significance are still unknown in healthy and IgG4-related diseased 
patients. As the pathogenesis of the IgG4 reaction in IgG4-related sclerosing cholangitis 
and pancreatitis, the participation of the Th2-type cytokine milieu and IL-10 produced 
by Treg cells is assumed to involve IgG4 class switching and/or the progressive 
proliferation/differentiation of IgG4+ plasma cells [10, 19, 28-30]. In the carcinogenesis 
of pancreatic cancer, the prevalence of Treg cells increases and that of cytotoxic CD8+ 
cells conversely diminishes in cancer tissues [20]. Moreover, the prevalence of Treg 
cells is negatively correlated with the prognosis of patients with pancreatic cancers [20]. 
These findings suggest that Treg cells play a role in controlling the immune response 
against pancreatic cancer, especially the evasion of tumor-associated immune 
surveillance. The present study using extrahepatic cholangiocarcinomas also 
demonstrated that in the IgG4-rich cases (≥10 IgG4+ cells/HPF), the number of IgG4 in 
cancer tissue positively correlated with the degree of Foxp3+ Treg cells and conversely 
the number of cytotoxic CD8+ CTLs was constantly small. Therefore, extrahepatic 
cholangiocarcinomas as well as pancreatic cancers could cause the evasion of immune 
surveillance via the regulatory function of Treg cells, involving the concomitant IgG4 
reaction. Survival curves also indicated the patients with ˂20 IgG4-positive cells/HPF 
to have a better prognosis than those with ≥20 cells. Although the role of IgG4+ plasma 
cells against cancer tissue is uncertain, the degree of IgG4+ plasma cell infiltration 
might be a pathological marker of prognosis in extrahepatic cholangiocarcinoma. 
In conclusion, this study revealed that extrahepatic cholangiocarcinoma often 
accompanies the significant infiltration of IgG4+ cells, indicating that we should take 
into account the differentiation of IgG4-related diseases and cholangiocarcinoma, 
especially using small specimens such as biopsy materials. Moreover, the IgG4 reaction 
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in cholangiocarcinoma might be associated with the evasion of immune surveillance by 
CD8+ CTLs and tumor progression through Treg cells. 
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Fig.1  Common bile duct cancer. A: Papillary adenocarcinoma and prominent 
inflammatory cells are found. B: Immunohistochemistry of IgG4. Numerous 
IgG4+ cells were present in the inflammed stroma.  





Fig.2  Common bile duct cancer. A: In a marginal zone (arrows) of poorly 
differentiated adenocarcinoma (Ca), many inflammatory cells are found. B: 
Higher magnification of the marginal zone. Inflammatory cells are mostly 
composed of plasma cells. C: Immunohistochemistry for IgG4. Many positive 
cells are scattered in the marginal zone.  




Fig.3  Gallbladder cancer. A: In an invasive area of poorly differentiated 
adenocarcinoma (Ca), numerous inflammatory cells are found. B: Higher 
magnification of the invasive area. Many plasma cells are found. C: 
Immunohistochemistry for IgG4. Several IgG4-positive cells are accumulated. 
D: Immunohistochemistry for Foxp3. Positive cells are diffusely scattered and 
slightly accumulated here and there.  




Fig.4 Relationship between IgG4+ cells and Treg cells in extrahepatic 
cholangiocarcinoma. In cases with ≥10/HPF IgG4+ cells (IgG4-rich cases), 
there is a good correlation between IgG4+ and the ratio of Foxp3+/CD4+ cells 
(R = 0.400 ).  




Fig.5  Comparison of CD8+ cytotoxic T cells in IgG4-rich (A and B) and -poor (C and 
D) cases of extrahepatic cholangiocarcinoma. Immunohistochemistry for IgG4 
(A and C) and CD8 (B and D). In IgG4-rich cases, CD8+ as well as IgG4+ cells 
are found around adenocarcinoma tissue, but no CD8+ cells are in cancer cells 
lining the adenocarcinoma. In contrast, many CD8+ cells invade within cancer 
cells lining adenocarcinoma in IgG4-poor cases.  




Fig.6  Relationship between IgG4+ and CD8+ cytotoxic T cells in extrahepatic 
cholangiocarcinoma. In all cases with ≥10/HPF IgG4+ cells (IgG4-rich cases), 
the number of CD8+ cells is less than 10.  




Fig.7  Survival curve of patients with extrahepatic cholangiocarcinoma. Kaplan-Meier 
plots of the postoperative survival period were carried out in two groups of 
patients, ˂20 and ≥20 IgG4+positive cells/HPF. Log-rank analysis of the 
postoperative survival periods indicated that cancer patients with ˂20 IgG4+ 
cells/HPF had better prognosis than those with ≥20 cells (p<0.05).  
 
